Completed from United Kingdom
I really enjoyed the course – it was exactly what I needed to get a grip on health‑economics basics. The casual teaching style made complex topics like budget impact analysis feel approachable. I especially liked the real‑world example where we assessed a new oncology drug for the NHS, which gave me a solid framework I can now use at work. The course notes were well‑structured and the interactive quizzes kept me on track. All in all, a solid learning experience that helped me meet my personal development goals.
The Pharmaceutical Health Economics course at Stanmore School of Business exceeded my expectations. The curriculum directly aligned with my goal to understand cost‑effectiveness analysis for new drug submissions. Through the hands‑on case study on a cardiovascular therapy, I learned how to build a Markov model and interpret incremental cost‑effectiveness ratios. The lecture slides were clear, and the supplementary datasets were up‑to‑date, which made the practical exercises feel realistic. Overall, the professional delivery and immediate applicability of the material have equipped me to contribute confidently to my company's health‑technology assessment team.
Wow! This course was fantastic! The enthusiastic instructors sparked my interest in health economics from day one. I walked away with practical skills like constructing a decision‑tree model for a diabetes medication and performing sensitivity analyses using real Indian market data. The video lectures were engaging, and the downloadable templates saved me tons of time. I even applied the learned techniques to a project at my pharmacy chain, which earned praise from senior management. I'm thrilled with the knowledge I gained and highly recommend it!
The course provided a detailed and thorough exploration of pharmaceutical health economics. My learning goal was to master health technology assessment methods, and the curriculum delivered this through step‑by‑step tutorials on cost‑utility analysis, complete with South African cost inputs. I appreciated the depth of the reading material, especially the peer‑reviewed articles that were directly relevant to emerging markets. The final project, which required me to evaluate a vaccine program, helped solidify my analytical skills. The overall experience was rigorous yet supportive, and I feel well‑prepared to apply these techniques in my role.
